COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 610: Articles 6091-6100  | Next

Associations of habitual fish oil use with risk of SARS-CoV-2 infection and COVID-19-related outcomes in UK: national population based cohort study
Ma, Y., Zhang, L., Zeng, R., Luo, D., Jiang, R., Wu, H., Zhuo, Z., Yang, Q., Li, J., Leung, F. W., Wang, J., Sha, W., Chen, H.
10.1101/2022.09.14.22279933 — Posted: 2022-09-17
Dynamics-informed deconvolutional neural networks for super-resolution identification of regime changes in epidemiological time series
Vilar, J., Saiz, L.
10.1101/2022.09.14.22279935 — Posted: 2022-09-17
High co-circulation of influenza and SARS-CoV-2
Kubale, J., Frutos, A. M., Balmaseda, A., Saborio, S., Ojeda, S., Barilla, C., Sanchez, N., Shotwell, A., Meyers, A., Lopez, R., Plazaola, M., Kuan, G., Gordon, A.
10.1101/2022.09.13.22279740 — Posted: 2022-09-17
Real World Effectiveness of Tixagevimab/cilgavimab (Evusheld) in the Omicron Era
Chen, B., Haste, N., Binkin, N., Law, N., Horton, L., Yam, N., Chen, V., Abeles, S. R.
10.1101/2022.09.16.22280034 — Posted: 2022-09-17
Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5 -Effect of Social Behavior-
Kodera, S., Niimi, Y., Rashed, E. A., Yoshinaga, N., Toyoda, M., Hirata, A.
10.1101/2022.09.15.22280010 — Posted: 2022-09-17
Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group.
Caze Ceron, A. B., Silva, T. C., Bomfim, A. P., de Souza, G. L., Azevedo, A. C. A., Brasil, M. Q. A., Santos, N. R., Khouri, R., Dan, J., Bandeira, A. C., Cavalcanti, L. P. d. G., Netto, M. B., Barral, A. M. P., Barbosa, C. G., Boaventura, V. S.
10.1101/2022.09.15.22279958 — Posted: 2022-09-17
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave
Yamamoto, S., Matsuda, K., Maeda, K., Horii, K., Okudera, K., Oshiro, Y., Inamura, N., TAKEUCHI, J. S., Konishi, M., Ozeki, M., Mizoue, T., Sugiyama, H., Aoyanagi, N., Mitsuya, H., Sugiura, W., Ohmagari, N.
10.1101/2022.09.15.22280009 — Posted: 2022-09-17
Hospital contact patterns and vulnerability to SARS-CoV-2 outbreaks
Shirreff, G., Huynh, B.-T., Duval, A., Pereira, L. C., Annane, D., Dinh, A., Lambotte, O., Bulifon, S., Guichardon, M., Beaune, S., Toubiana, J., Kermovant-Duchemin, E., Cheron, G., Cordel, H., Argaud, L., Douplat, M., Abraham, P., Tazarourte, K., Martin-Gaujard, G., Vanhems, P., Hilliquin, D., Nguyen, D., Chelius, G., Fraboulet, A., Temime, L., Opatowski, L., Guillemot, D.
10.1101/2022.09.13.22279837 — Posted: 2022-09-17
Differential contagiousness of respiratory disease across the United States
Mallela, A., Lin, Y. T., Hlavacek, W. S.
10.1101/2022.09.15.22279948 — Posted: 2022-09-17
Low Dimensional Chaotic Attractors in SARS-CoV-2's Regional Epidemiological Data
Goncalves, C. P. d. S.
10.1101/2022.09.16.22280044 — Posted: 2022-09-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).